Advertisement

Response of health insurance providers to cancer drug top-ups

With the announcement from the government that patients will be able to top up payments for cancer treatment and drugs themselves, Health-on-Line questions how health insurance providers will respond to the new challenges this poses.

Mike Dalby of Health-on-Line says: “The latest developments are obviously good news for patients who are unable to get the cancer treatment they need on the NHS and want to supplement what they are getting through private funding. Patients have two options when it comes to funding the NHS shortfall; they can pay for the treatment and drugs themselves or turn to existing private health insurance for support. Funding of any treatment, let alone cancer treatment, can run into many thousands of pounds and if funded personally by the patient it will not always be affordable. This is where private medical insurance can play a pivotal role.”

Many private health insurance providers offer policies that include an element of cancer cover, however, the real challenge is to design a specific product for individuals who only want cover for topping up cancer treatment that the NHS won’t or can’t fund.

Health-on-Line will be looking at how they can support individuals concerned about cancer treatment through innovative product design that answers their needs. In many cases it will be back to the drawing board in terms of product design and pricing.

 

Comment on this page »

Features

Latest news

Spire Harpenden Hospital wins prestigious industry award

New testing technique comes to The Royal Marsden

Bupa announce £2.9 million investment

Response of health insurance providers to cancer drug top-ups
Advertisement
Advertisement
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information